Perfil
Helen Hovenga is currently the Chief People Officer & Head-Human Resources at Nuchev Ltd. She previously worked as the Executive Director-People & Culture at Peter MacCallum Cancer Institute from 2018 to 2020 and as the Global Chief People Officer at Telix Pharmaceuticals Ltd. from 2021 to 2022.
Ms. Hovenga holds an MBA from Charles Sturt University and an undergraduate degree from Swinburne University of Technology.
Cargos activos de Helen Hovenga
| Empresas | Cargo | Inicio |
|---|---|---|
| NUCHEV LIMITED | Oficial de Recursos Humanos | 01/01/2023 |
Antiguos cargos conocidos de Helen Hovenga.
| Empresas | Cargo | Fin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Oficial de Recursos Humanos | 01/09/2022 |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services | Oficial de Recursos Humanos | 01/12/2020 |
Formación de Helen Hovenga.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Charles Sturt University
Charles Sturt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swinburne University of Technology
Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services | Government |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Nuchev Ltd.
Nuchev Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Develops, produces and sells milk based nutrition products | Consumer Non-Durables |
- Bolsa de valores
- Insiders
- Helen Hovenga
















